JPRN-UMIN000017603已完成2 期
A phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis (JCOG1310, PRECIOUS trial) - A phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis (JCOG1310, PRECIOUS trial)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 330 人开始时间: 2015年5月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma 2) Infectious disease to be treated 3) Positive for HBs antigen 4) Body temperature >= 38 degrees Celsius 5) Women during pregnancy, possible pregnancy or breast-feeding 6) Severe mental disease 7) Currently treated with systemic steroids or immunosuppressive agents 8) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema on chest CT 9) Uncontrollable diabetes mellitus or routine administration of insulin 10) Unstable angina pectoris or previous myocardial infarction within the past 6 months
研究者
相似试验
招募中
2 期
A randomized controlled phase II/III study comparing EBD combined with steroid to RIC combined with steroid for refractory anastomotic stricture after esophagectomy (JCOG1207: RICS study)Refractory anastomotic stricture after surgical resection for esophageal cancerJPRN-UMIN000014017Japan Clinical Oncology Group (JCOG)130
招募中
2 期
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90
招募中
1 期
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapyMetastatic or locally advanced leiomyosarcomaMedDRA version: 21.1Level: PTClassification code: 10024189Term: Leiomyosarcoma Class: 100000004864MedDRA version: 20.0Level: PTClassification code: 10024191Term: Leiomyosarcoma metastatic Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10024192Term: Leiomyosarcoma non-metastatic Class: 10029104CTIS2024-513820-40-00Italian Sarcoma Group100
尚未招募
2 期
A phase II Randomized controlled trial A comparison of short-course radiation and chemotherapy with or without intraperitoneal paclitaxel for locally advanced, non-metastatic signet-ring cell rectal cancersCTRI/2024/04/065785Tata Memorial Centre
进行中（未招募）
1 期
Study of efficacy and safety of NIS793 in combination with standard of care (SOC) chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC)Pancreatic ductal adenocarcinomaMedDRA version: 21.0Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 100000004864EUCTR2021-000591-10-HUovartis Pharma AG490